Coeptis Therapeutics Holdings, Inc.
- COEP
- NASDAQ
- Software - Services
- Cell Therapy Platforms
- Allogeneic Immunotherapy
$10.99
Today −8.57%Quote Jul 2, 2026, 07:59 PM UTC
−67.23%over the last month
Max drawdown −72.0%From 1-month high −67.7%3 months −56.6%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$546.8M
Approximate share count
Next earnings
—
Data unavailable
Latest analyst target
—
Data unavailable
Floor
$6.75
38.6% below price
Where the price sits
No analyst target range for this stock.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about COEPPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Software - Services
Employees
6
Founded
2017